Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for dermal fibroblasts from systemic sclerosis
Most Correlated Studies
- Dermal fibroblasts from normal and systemic sclerosis patients in response to rottlerin treatment
- Fibrotic and immune pathway signatures in dermal fibroblasts
- Dermal fibroblasts with siRNA-mediated Engrailed-1 knockdown and further treated with TGFb
- Dermal fibroblasts on collagen-adsorbed, aligned or randomly oriented nanofibers with TGFB1
- Primary keratinocytes treated with Interleukin-25
Most Relevant Literature
- Identification of lncRNA expression profiles in pediatric localized scleroderma.
- Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblas…
- Exosomes from human adipose-derived mesenchymal stem cells attenuate localized scleroderma fibrosis …
- The role of positional information in determining dermal fibroblast diversity.
- Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
Most Relevant Clinical Trials
- Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
- Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
- Imatinib in Systemic Sclerosis
- Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement
- Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
